Hitachi Ust-5311 Ultrasound Probe Pituitary Guidance Transducer for Arietta

Name: Hitachi Ust-5311 Ultrasound Probe Pituitary Guidance Transducer for Arietta
Brand: Shenzhen Reyardmed Technology Limited.
SKU: 2198356665

Guangdong, ChinaShenzhen Reyardmed Technology Limited.

US$1,000.00-5,000.00

1 Piece

Product profile

Customization

Available

Customized

Certification

CE, FDA, ISO13485

Model NO.

UST-5311

Scale

Medium

Brand

Hitachi

Model

Ust-5311

Type

Linear

Frequency Range

17-4 MHz

Compatible Systems

Arietta

Applications

Pituitary Guidance

Materials

Metal, Plastics

Warranty

Six Months

Transport Package

Common Box

Origin

China

HS Code

9018129190

Production Capacity

50000PCS/Year

Key features

Customized Options: Product is available in customized configurations to meet specific needs.

CE Certification: Product meets CE safety and quality standards for medical devices.

Linear Transducer Type: Designed with linear array technology for pituitary guidance applications.

Wide Frequency Range: Operates within 17-4 MHz range for versatile imaging capabilities.

Arietta Compatibility: Fully compatible with Arietta ultrasound systems for seamless integration.

Durable Materials: Constructed with high-quality metal and plastics for long-term durability.

One Year Warranty: Covers mechanical defects with replacement or refund options during the period.

Global Shipping: Available for delivery to North America, Europe, Asia, Africa, and other regions.

Company profile

Shenzhen Reyardmed Technology Limited.

Guangdong, China

Business Type: Trading CompanyAverage Response Time: ≤1.56h

AI-Powered supplier vetting

SummaryThe supplier is a limited trading company offering ultrasound probes and related medical-device, technology, rental, consulting, and trading services. It reports ISO 13485 certification, 11–20 years of combined R&D-engineer experience, 6–10 quality-control staff, broad export coverage, and order fulfillment within 15 working days in both peak and off-peak periods. However, it does not provide OEM services for popular brands or an SDK, and the available quality-control evidence identifies zero quality-control test equipment, no written corrective/preventive-action or complaint-handling procedures, and unknown quality-assurance and traceability status. Financial records are referenced for 2022–2024, but no usable financial performance figures are provided. Customer relationships across multiple regions are described, but no specific customer cases are named.

CertificationsThe supplier reports holding ISO 13485 certification, a medical-device quality-management certification. The slices do not provide the certificate number, validity period, certification scope, or product coverage, so the certification is evidenced but its applicability cannot be fully assessed.

After-Sales capabilityThe supplier describes support from pre-sales consultation through after-sales technical assistance and states that it serves hospitals, clinics, and distributors internationally. However, it also reports no written procedures or records for corrective and preventive actions or customer-complaint handling, which shows a documented service-process deficiency despite the stated support commitment.

Production capacityThe supplier offers ultrasound probes, reports an annual production-output range, exports to multiple regions, and states order fulfillment within 15 working days in both peak and off-peak seasons. Against these positive operational indicators, the quality-control slice reports zero quality-control test equipment and unknown quality-assurance and traceability status, creating a clear documented weakness in production-quality infrastructure.

Customization capabilityThe supplier lists technology development, consultation, exchange, transfer, and technical services, and has reported R&D-engineer experience. However, it explicitly does not provide OEM services for popular brands and has no available SDK; no other product-customization process or capabilities are documented.